InsiderSignalSign in
← Insider buys

Bhavesh Ashar has sold SWTX and made no open-market buys since Feb 2024

Chief Commercial Officer at Springworks Therapeutics, Inc.

SEC CIK 0001849740 · Filings on SEC.gov ↗

$0Bought
$381KSold
NoneLast buy

Every filing

1 filing since Feb 2024, newest first

SWTXSell

Springworks Therapeutics, Inc.

Chief Commercial Officer

$381K−12.0%Feb 5

Filings come from SEC EDGAR. Not investment advice.